Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
13 Feb
Full Year Report 2024
The full year report 2024 is published on 13 February 2025.
-
13 Feb
Interim Report January-December 2024 – Audiocast
Financial analysts and media are invited to attend a telephone conference and presentation of the fourth quarter results at 2.00 pm CET. Audiocast
-
11 Mar
Carnegie Nordic Healthcare Seminar
Camurus' President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 11 March. More information will follow closer to the event.
Latest financial report
Camurus’ Interim Report Third Quarter 2024
7 November 2024
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
